Erythrocyte transketolase deficiency in patients suffering from Crohn's disease

D Mańkowska-Wierzbicka1, S Michalak, J Karczewski

  • 1Department of Gastroenterology, Metabolic Diseases, Internal Medicine and Dietetics, Poznan University of Medical Sciences, Poznan, Poland. stelmach@ump.edu.pl.

Insights

Vitamin B1 deficiency is linked to worsening Crohn's disease (CD) in adults. This study found lower vitamin B1 levels in patients with moderate-to-severe active CD, indicating a significant nutritional deficit.

Area of Science:

  • Gastroenterology
  • Nutritional Science
  • Biochemistry

Background:

  • Crohn's disease (CD) is a chronic inflammatory bowel disease.
  • Nutritional deficiencies are common in CD patients, impacting disease activity.
  • The role of vitamin B1 (thiamine) in CD exacerbation requires further investigation.

Purpose of the Study:

  • To evaluate the potential association between vitamin B1 deficiency and the exacerbation of Crohn's disease in adult patients.
  • To assess vitamin B1 status in CD patients with varying disease activity levels.

Main Methods:

  • Included 49 adult CD patients with diverse disease activity (Crohn's Disease Activity Index - CDAI).
  • Assessed anthropometrical and biochemical markers, including high-sensitivity C-reactive protein (hsCRP).
  • Measured erythrocyte transketolase activity (TK) using spectrophotometry, calculating normalized transketolase activity ratio (NTKZ) and percentage of activation with thiamine pyrophosphate (%TPP).

Main Results:

  • CD patients exhibited a poor nutritional status, with mean BMI near the 18.5 kg/m2 cut-off.
  • Moderate-to-severe active CD patients showed significantly higher CDAI and hsCRP levels compared to those in remission or mild activity.
  • Statistically significant differences in NTKZ and %TPP levels were observed, indicating vitamin B1 deficiency in moderate-to-severe active CD patients.

Conclusions:

  • Vitamin B1 deficiency is a component of the clinical manifestation in moderate-to-severe active Crohn's disease.
  • These findings highlight the importance of assessing vitamin B1 status in CD management.
Abstract

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
443
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.3K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
424
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
17.4K
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
154.9K